Literature DB >> 11349151

Relapse to cocaine-seeking after hippocampal theta burst stimulation.

S R Vorel1, X Liu, R J Hayes, J A Spector, E L Gardner.   

Abstract

Treatment efforts for cocaine addiction are hampered by high relapse rates. To map brain areas underlying relapse, we used electrical brain stimulation and intracranial injection of pharmacological compounds after extinction of cocaine self-administration behavior in rats. Electrical stimulation of the hippocampus containing glutamatergic fibers, but not the medial forebrain bundle containing dopaminergic fibers, elicited cocaine-seeking behavior dependent on glutamate in the ventral tegmental area. This suggests a role for glutamatergic neurotransmission in relapse to cocaine abuse. The medial forebrain bundle electrodes supported intense electrical self-stimulation. These findings suggest a dissociation of neural systems subserving positive reinforcement (self-stimulation) and incentive motivation (relapse).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349151     DOI: 10.1126/science.1058043

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  159 in total

Review 1.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

2.  A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period.

Authors:  Adam Bisaga; Efrat Aharonovich; Wendy Y Cheng; Frances R Levin; John J Mariani; Wilfrid N Raby; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

3.  Hippocampal GluA1-containing AMPA receptors mediate context-dependent sensitization to morphine.

Authors:  Yan Xia; George S Portugal; Amanda K Fakira; Zara Melyan; Rachael Neve; H Thomas Lee; Scott J Russo; Jie Liu; Jose A Morón
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 4.  Brain circuitry and the reinstatement of cocaine-seeking behavior.

Authors:  Peter W Kalivas; Krista McFarland
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

5.  Psychostimulant-induced plasticity of intrinsic neuronal excitability in ventral subiculum.

Authors:  Donald C Cooper; Shannon J Moore; Nathan P Staff; Nelson Spruston
Journal:  J Neurosci       Date:  2003-10-29       Impact factor: 6.167

6.  Disrupting the memory of places induced by drugs of abuse weakens motivational withdrawal in a context-dependent manner.

Authors:  Stephen M Taubenfeld; Elizaveta V Muravieva; Ana Garcia-Osta; Cristina M Alberini
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

7.  Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.

Authors:  Xiaomeng Xu; Uraina S Clark; Sean P David; Richard C Mulligan; Valerie S Knopik; John McGeary; James MacKillop; Jeanne McCaffery; Raymond S Niaura; Lawrence H Sweet
Journal:  Nicotine Tob Res       Date:  2014-03-22       Impact factor: 4.244

Review 8.  "Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Oluwatosin O Fatusin; Qing-Rong Liu; Carlo Contoreggi; Chuan-Yun Li; Kari Buck; John Crabbe
Journal:  Biochem Pharmacol       Date:  2007-07-25       Impact factor: 5.858

9.  Bidirectional effects of fentanyl on dendritic spines and AMPA receptors depend upon the internalization of mu opioid receptors.

Authors:  Hang Lin; Paul Higgins; Horace H Loh; Ping-Yee Law; Dezhi Liao
Journal:  Neuropsychopharmacology       Date:  2009-03-18       Impact factor: 7.853

10.  Exploring the molecular basis of addiction: drug-induced neuroadaptations.

Authors:  Jose A Morón; Thomas A Green
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.